About Blood Immunology & Cellular Therapy

Blood Immunology & Cellular Therapy provides an international platform for publishing original research in basic, translational, and clinical investigations related to cellular and non-cellular immunotherapies for both hematological and selected non-hematological conditions and the underlying immunology.

The scope includes:

• Cellular therapies, such as CAR-T cells, TCR-engineered T-cells, CAR-NK cells, NK cells, T-Regs and mesenchymal stromal cells (MSC)
• Gene therapies, including vector design, gene editing (CRISPR-Cas9, base editing)
• Ex-vivo/in-vivo approaches for congenital conditions like primary immune deficiencies, hemoglobinopathies, metabolic disorders and hemophilia
• Non-cellular therapies like vaccinations, monoclonal antibodies (e.g., bispecific antibodies and BiTEs), antibody-drug conjugates, and immune checkpoint inhibitors